The 35 rating InvestorsObserver gives to Canopy Growth Corp (CGC) stock puts it near the middle of the Drug Manufacturers - Specialty & Generic industry. In addition to scoring higher than 62 percent of stocks in the Drug Manufacturers - Specialty & Generic industry, CGC’s 35 overall rating means the stock scores better than 35 percent of all stocks.
What do These Ratings Mean?
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With Canopy Growth Corp Stock Today?
Canopy Growth Corp (CGC) stock is trading at $15.10 as of 11:14 AM on Wednesday, Apr 22, an increase of $0.06, or 0.4% from the previous closing price of $15.04. The stock has traded between $14.86 and $15.48 so far today. Volume today is less active than usual. So far 1,554,874 shares have traded compared to average volume of 5,785,255 shares.
To see the top 5 stocks in Drug Manufacturers - Specialty & Generic click here.
